e512b50460a51564d926830abb3cce90fa9cd866
Home.md
| ... | ... | @@ -4,6 +4,8 @@ bibliography: 'morinlab.bib' |
| 4 | 4 | link-citations: true |
| 5 | 5 | --- |
| 6 | 6 | |
| 7 | +[[_TOC_]] |
|
| 8 | + |
|
| 7 | 9 | # Welcome to Lymphopedia! |
| 8 | 10 | |
| 9 | 11 | |
| ... | ... | @@ -15,7 +17,6 @@ To get started, select one of the gene lists from the table below then select th |
| 15 | 17 | |
| 16 | 18 | ## Common B-cell lymphomas |
| 17 | 19 | |
| 18 | - |
|
| 19 | 20 | |Entity|Tier 1 (high-confidence)|Tier 2 (low-confidence)|Tier 3 (retired) | |
| 20 | 21 | |:-:|:-:|:-:|:-:| |
| 21 | 22 | |BL [(tsv)](https://raw.githubusercontent.com/morinlab/LLMPP/main/resources/curated/bl_genes.tsv)|[32 genes](BL_genes#tier-1-bl-genes)|[72 genes](BL_genes#tier-2-bl-genes)|[70 genes](BL_genes#tier-3-bl-genes)| |
| ... | ... | @@ -34,7 +35,7 @@ config: |
| 34 | 35 | showValues: false |
| 35 | 36 | linkColor: target |
| 36 | 37 | width: 750 |
| 37 | - height: 1150 |
|
| 38 | + height: 1350 |
|
| 38 | 39 | nodeAlignment: left |
| 39 | 40 | --- |
| 40 | 41 | sankey-beta |
| ... | ... | @@ -171,7 +172,7 @@ config: |
| 171 | 172 | showValues: false |
| 172 | 173 | linkColor: target |
| 173 | 174 | width: 750 |
| 174 | - height: 1050 |
|
| 175 | + height: 1350 |
|
| 175 | 176 | nodeAlignment: right |
| 176 | 177 | --- |
| 177 | 178 | sankey-beta |
| ... | ... | @@ -290,11 +291,13 @@ PMBL panel, Desch 2020, 10 |
| 290 | 291 | |
| 291 | 292 | ### Tiers |
| 292 | 293 | |
| 293 | -**Tier 2** - Any gene described as significantly or recurrently mutated in one or more types of B-cell lymphoma is initially assigned to Tier 2 for that entity. The study describing the mutation of that gene in a particular entity is considered the originating study. |
|
| 294 | +**Tier 2** - Any gene described as significantly or recurrently mutated in one or more types of B-cell lymphoma is initially assigned to Tier 2 for that entity. The study describing the mutation of that gene in a particular entity is considered the originating study. |
|
| 295 | + |
|
| 296 | +**Tier 1** - Genes can transition to Tier 1 only after additional studies have demonstrated the recurrence of mutations in the same entity. |
|
| 294 | 297 | |
| 295 | -**Tier 1** - Genes can transition to Tier 1 only after additional studies have demonstrated the recurrence of mutations in the same entity. |
|
| 298 | +**Tier 3** - Tier 3 is reserved for genes that were once nominated as a driver but have since been retired due to a lack of support in the original study nominating them. |
|
| 296 | 299 | |
| 297 | -**Tier 3** - Tier 3 is reserved for genes that were once nominated as a driver but have since been retired due to a lack of support in the original study nominating them. |
|
| 300 | +For more details, visit (this page)(Supplemental_Methods_and_Results) |
|
| 298 | 301 | |
| 299 | 302 | ## Other resources available for each gene |
| 300 | 303 |